Download INFORMTM HER2 - HER
Transcript
Method 2A: Additional Quantitative in both target areas (40 cells) by the total number of For cases that have been enumerated using Method 2 Chr17 signals in both target areas (40 cells). Results are and have a HER2/Chr17 ratio either equal to or between reported as: 1.8 and 2.2, Method 2A must be utilized. The reader a. N egative for HER2 gene amplification. Defined as a HER2/Chr17 ratio less than 1.8. selects a second target area for each of HER2 and Chr17 b. E quivocal for HER2 gene amplification. Defined as a and counts the number of signals in 20 additional nuclei. The HER2/Chr17 ratio using counts from both target HER2/Chr17 ratio equal to or between 1.8 and 2.2. areas is then calculated. A total of 40 nuclei will have c. P ositive for HER2 gene amplification. Defined as a HER2 Chr17 ratio greater than 2.2. been read between both target areas. Calculate the HER2/ Chr17 ratio by dividing the total number of HER2 signals Figure 11. Method 2A Scoring Algorithm 1.8 HER2/Chr17 Ratio 1.0 2.2 3.0 2.0 Negative for HER2 Gene Amplification Equivocal 5.0 6.0 Positive for HER2 Gene Amplification Method 2A Start Method 2A HER2 stained slide Identify and select target area 2 Count HER2 signals in 20 nuceli Chr17 stained slide Locate target area 2. Count Chr17 signals in 20 nuceli. Calculate HER2/Chr17 ratio by dividing the total number of HER2 signals from target area 1 and 2 by the total number of Chr17 signals fron target area 1 and 2 Report Results Negative HER2/Chr17 < 1.8 Equivocal 1.8 ≤ HER2/Chr17 ≤ 2.2 Positive HER2/Chr17 > 2.2 800 227 2155 www.ventanamed.com 11